Ryan Zimmerman
Stock Analyst at BTIG
(4.22)
# 267
Out of 4,805 analysts
174
Total ratings
50.68%
Success rate
11.83%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $87 → $91 | $70.98 | +28.21% | 11 | Dec 12, 2024 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $41.90 | +57.52% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $268.57 | +0.53% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $89.66 | +66.18% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $489.52 | +14.60% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $348.39 | +13.09% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $1.57 | +536.94% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $87.00 | +21.84% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $17.42 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $102.26 | +23.22% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $62.28 | +60.57% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $65.17 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $14.19 | +414.45% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $15.57 | +240.40% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.38 | +685.62% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.99 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.63 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.21 | +230.58% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.75 | +60.00% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.43 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $21.39 | +143.10% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.92 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $13.40 | +108.96% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $151.49 | +32.02% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $251.47 | +39.18% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $124.50 | +4.42% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $50.73 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $82.54 | +55.08% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $13.40 | +11.94% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $57.16 | +59.20% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $15.05 | +179.07% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.52 | +851.09% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.80 | - | 3 | Apr 2, 2020 |
Globus Medical
Dec 12, 2024
Maintains: Buy
Price Target: $87 → $91
Current: $70.98
Upside: +28.21%
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $41.90
Upside: +57.52%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $268.57
Upside: +0.53%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $89.66
Upside: +66.18%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $489.52
Upside: +14.60%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $348.39
Upside: +13.09%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $1.57
Upside: +536.94%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $87.00
Upside: +21.84%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $17.42
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $102.26
Upside: +23.22%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $62.28
Upside: +60.57%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $65.17
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $14.19
Upside: +414.45%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $15.57
Upside: +240.40%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.38
Upside: +685.62%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.99
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.63
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.21
Upside: +230.58%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $3.75
Upside: +60.00%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.43
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $21.39
Upside: +143.10%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $13.92
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $13.40
Upside: +108.96%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $151.49
Upside: +32.02%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $251.47
Upside: +39.18%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $124.50
Upside: +4.42%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $50.73
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $82.54
Upside: +55.08%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $13.40
Upside: +11.94%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $57.16
Upside: +59.20%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $15.05
Upside: +179.07%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.52
Upside: +851.09%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $15.80
Upside: -